© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Closing The Gender Gap In Cybersecurity Could Boost UK Economy By £12.6bn
Leadership
20/03/2020Closing The Gender Gap In Cybersecurity Could Boost UK Economy By £12.6bn

Increasing the number of women working in cybersecurity could boost the UK economy by £12.6 billion according to a new report from Tessian, the human layer security company. The report also reveals that closing the 24% gender pay gap in the UK cybersecurity i

Read Full PostRead - Eye Icon
YFM Equity Partners announces £60m first close of its Buy-Out Fund II
Finance
12/06/2019YFM Equity Partners announces £60m first close of its Buy-Out Fund II

YFM Equity Partners (YFM) announces the first close of its Buy-Out-Fund II with £60m of investment committed. This follows the £45m raised for its Buy-Out Fund I, which had a final close in April 2017. Only two years later, and following the recent investmen

Read Full PostRead - Eye Icon
The Role of Construction Accident Statistics in Business Planning and Risk Management
News
16/10/2024The Role of Construction Accident Statistics in Business Planning and Risk Management

Construction accident statistics are the central component of risk management in the construction industry. By analyzing and understanding accident data, companies can identify potential hazards, implement safety measures, create a safer environment for their

Read Full PostRead - Eye Icon
How Intelligent Process Automation (IPA) Can Transform Your Business
Innovation
16/03/2023How Intelligent Process Automation (IPA) Can Transform Your Business

Most companies use automation tools to increase the efficiency of their processes. As an entrepreneur, it’s best to keep up with the competition by doing the same thing. However, most of these automation technologies require human intervention.

Read Full PostRead - Eye Icon
Seven Contracts Every Startup Should Be Aware Of
Legal
07/06/2023Seven Contracts Every Startup Should Be Aware Of

Starting a business is a challenging and exciting process, with founders expected to have a thorough understanding of numerous different legal processes. Startup founders need to be familiar with the different types of contracts they require to ensure their bu

Read Full PostRead - Eye Icon
5 Strategies to Maximize Commercial Real Estate Revenue
News
01/07/20225 Strategies to Maximize Commercial Real Estate Revenue

Looking for ways to maximize your revenue if you work in commercial real estate is constant. You can do a lot to boost your income, but it's also possible to make mistakes that hurt your bottom line.

Read Full PostRead - Eye Icon
Placing Ethical and Human Values at the Heart of all Relationships
Legal
30/08/2019Placing Ethical and Human Values at the Heart of all Relationships

UrbanLaw Avocats provides legal advice and assistance to public entities (national or local), as well as major French and international groups. Following their success in AI’s Global Excellence Awards 2019 where they were selected as the Best Urban Planning

Read Full PostRead - Eye Icon
The Cyber Risk That Surfaces After the Deal Closes
Technology
28/08/2026The Cyber Risk That Surfaces After the Deal Closes

The Cyber Risk That Surfaces After the Deal Closes In mergers and acquisitions, the value of a target is scrutinised from every angle. Financials are audited, contracts are reviewed, liabilities are quantified, and growth assumptions are stress-tested. Yet one

Read Full PostRead - Eye Icon
Innovative Healthcare Benefits: How Medicare Enhances Employee Recruitment and Retention
News
01/09/2023Innovative Healthcare Benefits: How Medicare Enhances Employee Recruitment and Retention

In today’s rapidly evolving job market, where top-tier talent is in high demand and competition among employers is fierce, crafting a comprehensive employee benefits package has become a critical factor in attracting and retaining skilled professionals. Whil



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow